Artificial intelligence tools predict DNA’s regulatory role and 3D structure
Sequence modeling algorithms could eventually lead to new ways to fight diseases caused by genetic mutations
DALLAS – August 08, 2022 – Newly developed artificial intelligence (AI) programs accurately predicted the role of DNA’s regulatory elements and three-dimensional (3D) structure based solely on its raw sequence, according to two recent studies in Nature Genetics. These tools could eventually shed new light on how genetic mutations lead to disease and could lead to new understanding of how genetic sequence influences the spatial organization and function of chromosomal DNA in the nucleus, said study author Jian Zhou, Ph.D., Assistant Professor in the Lyda Hill Department of Bioinformatics at UTSW.
“Taken together, these two programs provide a more complete picture of how changes in DNA sequence, even in noncoding regions, can have dramatic effects on its spatial organization and function,” said Dr. Zhou, a member of the Harold C. Simmons Comprehensive Cancer Center, a Lupe Murchison Foundation Scholar in Medical Research, and a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar.
Only about 1% of human DNA encodes instructions for making proteins. Research in recent decades has shown that much of the remaining noncoding genetic material holds regulatory elements – such as promoters, enhancers, silencers, and insulators – that control how the coding DNA is expressed. How sequence controls the functions of most of these regulatory elements is not well understood, Dr. Zhou explained.
To better understand these regulatory components, he and colleagues at Princeton University and the Flatiron Institute developed a deep learning model they named Sei, which accurately sorts these snippets of noncoding DNA into 40 “sequence classes” or jobs – for example, as an enhancer for stem cell or brain cell gene activity. These 40 sequence classes, developed using nearly 22,000 data sets from previous studies studying genome regulation, cover more than 97% of the human genome. Moreover, Sei can score any sequence by its predicted activity in each of the 40 sequence classes and predict how mutations impact such activities.
By applying Sei to human genetics data, the researchers were able to characterize the regulatory architecture of 47 traits and diseases recorded in the UK Biobank database and explain how mutations in regulatory elements cause specific pathologies. Such capabilities can help gain a more systematic understanding of how genomic sequence changes are linked to diseases and other traits. The findings were published this month.
In May, Dr. Zhou reported the development of a different tool, called Orca, which predicts the 3D architecture of DNA in chromosomes based on its sequence. Using existing data sets of DNA sequences and structural data derived from previous studies that revealed the molecule’s folds, twists, and turns, Dr. Zhou trained the model to make connections and evaluated the model’s ability to predict structure at various length scales.
The findings showed that Orca predicted DNA structures both small and large based on their sequences with high accuracy, including for sequences carrying mutations associated with various health conditions including a form of leukemia and limb malformations. Orca also enabled the researchers to generate new hypotheses about how DNA sequence controls its local and large-scale 3D structure.
Dr. Zhou said that he and his colleagues plan to use Sei and Orca, which are both publicly available on web servers and as open-source code, to further explore the role of genetic mutations in causing the molecular and physical manifestations of diseases – research that could eventually lead to new ways to treat these conditions.
The Orca study was supported by grants from CPRIT (RR190071), the National Institutes of Health (DP2GM146336), and the UT Southwestern Endowed Scholars Program in Medical Science.
About UT Southwestern Medical Center
UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 26 members of the National Academy of Sciences, 17 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,900 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 100,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 4 million outpatient visits a year.